Today in Oncology
Growth-Driving Cancer Cells May Be Better Targets for Therapy Than Cells T...7/31/2014 4:02:48 PM - The ASCO Post
Results of Genomic Analysis Suggest Strategy for Overcoming Ibrutinib Resi...7/31/2014 3:32:25 PM - Jo Cavallo
Considerable Extension of Survival Achieved With Conventional Treatment in...July 25, 2014, Volume 5, Issue 12 - Caroline Helwick
Minimal Residual Disease–Based Risk-Directed Therapy Is Effective in Child...7/31/2014 2:43:19 PM - Matthew Stenger
Adults With Exclusively Pulmonary Metastases From Ewing Sarcoma May Benefi...7/31/2014 2:40:50 PM - Susan Reckling
International Leader in Urology, Professor John Fitzpatrick, DiesJuly 25, 2014, Volume 5, Issue 12 - Ronald Piana
Anti–IL-6 Antibody Siltuximab Produces Durable Responses in Multicentric C...7/31/2014 2:37:01 PM - Matthew Stenger
Researchers Identify Genetic Mutations Linked to Salivary Gland Tumors7/30/2014 3:42:36 PM - The ASCO Post
How to Recognize and Manage Intertriginous Eruptions Related to Doxorubici...July 25, 2014, Volume 5, Issue 12 - Lida Zheng, BS, and Milan J. Anadkat, MD
Acupuncture Provides Significant Quality-of-Life Improvements Among Breast...7/30/2014 1:41:54 PM - The ASCO Post
African Americans More Likely Than Whites to Receive Analgesic With Toxic ...7/30/2014 1:38:00 PM - Matthew Stenger
Improved Overall Survival With Primary Over Consolidation Intraperitoneal ...7/30/2014 1:35:05 PM - Susan Reckling
Neoadjuvant Chemotherapy Less Invasive Option for Advanced Ovarian Cancer,...July 25, 2014, Volume 5, Issue 12 - Alice Goodman
Phase Ib Study Shows Activity of Ibrutinib Plus R-CHOP in First-Line Treat...7/30/2014 1:31:55 PM - Matthew Stenger
Study Helps Compare Risks of Endoscopic vs Surgical Resection for Early Es...7/29/2014 4:32:10 PM - The ASCO Post
Vaccine Targeting Tumor Antigen to Dendritic Cell Receptors Induces Antige...July 25, 2014, Volume 5, Issue 12 - Matthew Stenger
Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation7/29/2014 3:56:48 PM - The ASCO Post
Combination Afatinib and Cetuximab Yields Benefit in Lung Cancer Patients ...7/29/2014 2:05:25 PM - Jo Cavallo
Investigational Immunotherapy Demonstrates Response in Patients With PD-L1...July 25, 2014, Volume 5, Issue 12 - The ASCO Post
Promising Phase Ib Findings With Combined BRAF and MEK Inhibition With Vem...7/29/2014 12:43:49 PM - Matthew Stenger
Study Identifies Prevalence of Uterine Malignancy and Endometrial Hyperpla...7/29/2014 10:58:27 AM - Matthew Stenger
Failure to Adopt a Healthy Lifestyle More Than Doubles Risk of Metabolic S...7/28/2014 4:17:37 PM - The ASCO Post
ASPHO Abstracts Cover Broad Range of TopicsJuly 25, 2014, Volume 5, Issue 12 - Charlotte Bath
First Surveillance Imaging at 6 Months May Be Adequate for Most Patients A...7/28/2014 3:40:22 PM - Susan Reckling
FDA Expands Approved Use of Ibrutinib for Chronic Lymphocytic Leukemia7/28/2014 3:31:15 PM - The ASCO Post
ASCO Clinical Practice Guideline: Disease Management in Advanced HER2-Posi...July 10, 2014, Volume 5, Issue 11 - Matthew Stenger
Phase II Trial Supports Use of First-Line Sunitinib vs Everolimus in Seque...7/28/2014 12:36:55 PM - Matthew Stenger
Adding Induction Chemotherapy to Chemoradiotherapy Does Not Improve Surviv...7/28/2014 11:50:59 AM - Matthew Stenger
Discontinuing Statins Near the End of Life Is Safe, Can Reduce Symptom Bur...July 10, 2014, Volume 5, Issue 11 - Charlotte Bath
Statin Use Associated With Decreased Risk of Barrett's Esophagus7/24/2014 3:46:31 PM - The ASCO Post
New Molecular Test Increases Odds of Correct Surgery for Thyroid Cancer Pa...7/24/2014 3:21:13 PM - The ASCO Post
Adaptive Intensity-Modulated Radiation Therapy Strategy May Ensure Adequat...7/24/2014 2:44:33 PM - Joseph Cupolo
Rilotumumab Added to First-Line Chemotherapy May Benefit Patients With Adv...July 25, 2014, Volume 5, Issue 12 - Matthew Stenger
Dutch Phase II Study Supports Phase III Evaluation of Bevacizumab Plus Lom...7/24/2014 12:58:11 PM - Matthew Stenger
Higher Plasma Vitamin D Concentration Associated With Reduced Cancer-Speci...7/24/2014 12:32:57 PM - Matthew Stenger
Stakeholders Are Uniting Around Value in Cancer CareJuly 25, 2014, Volume 5, Issue 12 - Caroline Helwick
Antipain Agent Shrinks Oral Cancers, Sparing Healthy Tissue7/23/2014 3:52:24 PM - The ASCO Post
Combined BRAF V600E and TERT Promoter Mutations Identify Aggressive and Re...7/23/2014 3:02:32 PM - Matthew Stenger
AR-V7 Predicts Resistance to Enzalutamide and Abiraterone in Men With Cast...July 10, 2014, Volume 5, Issue 11 - Alice Goodman
Study Defines Four Molecular Subtypes of Gastric Cancer7/23/2014 2:43:39 PM - Jo Cavallo
Featured Columnists
Take-Home Messages From ASCO's Immediate Past President
Clifford A. Hudis, MD, FACP
The More Things Change, the More They Stay the Same
Jimmie C. Holland, MD, and James F. Holland, MD
Time to Move Forward With Lung Screening
James L. Mulshine, MD
Expert Opinions
The Road to Progress in Lung Cancer Treatment
Giuseppe Giaccone, MD, PhD
ASCO Convenes Think Tank to Tackle Disparities in Cancer Care
Blase N. Polite, MD, MPP
Advancing Immune Checkpoint Targeting in Cancer Treatment
James P. Allison, PhD
Meeting News
Considerable Extension of Survival Achieved With Conventional Treatment in... Stakeholders Are Uniting Around Value in Cancer Care Multiple Myeloma Studies Explore Roles of Panobinostat in Relapsed/Refract... Neoadjuvant Chemotherapy Less Invasive Option for Advanced Ovarian Cancer,... More Meeting NewsJournal Spotlight
Sorafenib Improves Progression-Free Survival in Progressive Radioactive Io... Rilotumumab Added to First-Line Chemotherapy May Benefit Patients With Adv... Swiss Medical Board Members Discuss Recommendation to Phase Out Mammograph... HIV-Infected People With Early-Stage Cancers Are Up to Four Times More Lik... More Journal SpotlightsHealth-Care Policy
IOM Workshop Explores Growing Problems in Patient Access to Cancer Drugs ASCO Convenes Think Tank to Tackle Disparities in Cancer Care Cancer Care Under the Affordable Care Act Medicare Advisory Panel Cast Doubts on Lung Cancer Screening, Leaving Advocates Dismayed but Undaunted More Health-care PolicyDrugs & Regimens
Benefit Confirmed for Adjuvant Oxaliplatin in Rectal Cancer Impressive Delay in Thyroid Cancer Progression Achieved With Lenvatinib Considerable Extension of Survival Achieved With Conventional Treatment in Grade 2 Glioma Multiple Myeloma Studies Explore Roles of Panobinostat in Relapsed/Refractory Disease and Thalidomide Compared to Lenalidomide as Part of Initial Therapy More Drugs & RegimensOncology Worldwide
From Ireland to America and Back, Patrick G. Johnston, MD, PhD, Thrives on Bringing Research Findings to Clinical Practice Improving Quality of Life in Cancer Survivors A Vision of Independent Clinical Research in South America National Program to Screen Ashkenazi Women in Israel for BRCA Mutations Is Being Explored More Oncology Worldwide
Current Issue
July 25, 2014
Volume 5, Issue 12
View the
digital edition of
The ASCO Post
Supplement
Narratives in Oncology
advertisement
CATEGORIES
Breast cancerProstate cancerAppointmentsLeukemiaLung cancerDirect from ASCOColorectal cancerLymphomaAwardsIntegrative careMultiple myelomaGastrointestinal cancerOtherMelanomaMolecular researchHead and Neck cancerTechnologyRenal cell cancerDrug safetyHealth-care policyPerspective More Categories
advertisement